Latest On Soligenix, Inc (SNGX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-16 18:58 EST | News | Soligenix secures European patent for Dusquetide's application in oral mucositis treatment | N/A |  |
| 2023-05-15 15:02 EST | News | Soligenix GAAP EPS of -$0.36, revenue of $0.3M | N/A | |
| 2023-05-11 10:41 EST | News | Soligenix gets FDA meeting to discuss phase 3 trial design of photodynamic therapy HyBryte | N/A | |
| 2023-05-05 18:50 EST | News | Soligenix prices stock and warrants offering to raise $8.5M, shares down nearly 50% | N/A | |
| 2023-05-04 16:52 EST | News | Soligenix surges ~250% after HyBryte shows compatibility with light device for blood cancer | N/A | |
| 2023-04-24 10:22 EST | News | Soligenix requests FDA meeting to review study design for cancer treatment | N/A | |
| 2023-04-14 17:01 EST | News | Soligenix stock sinks as FDA seeks additional positive results for cancer drug | N/A | |
| 2023-03-31 10:33 EST | News | Soligenix GAAP EPS of -$4.81 misses by $3.68, revenue of $0.9M beats by $0.7M | N/A | |
| 2023-03-09 22:30 EST | News | Soligenix seeks FDA meeting for review of cancer photodynamic therapy | N/A | |
| 2023-02-14 13:35 EST | News | Soligenix's stock slumps ~35% as FDA declines to review photodynamic therapy for cancer | N/A | |
| 2023-02-09 15:55 EST | News | Soligenix to implement 1-for-15 reverse stock split | N/A | |
| 2022-12-15 16:03 EST | News | Soligenix stock jumps 10% on filing seeking FDA approval of photodynamic therapy for cancer | N/A | |
| 2022-11-10 23:27 EST | News | Soligenix GAAP EPS of -$0.08 beats by $0.01, revenue of $0.2M in-line | N/A | |
| 2022-10-05 11:47 EST | News | Soligenix: A Biotech Bargain Ready To File For Approval In Cutaneous T-Cell Lymphoma | N/A | |
| 2022-09-13 00:07 EST | News | U.S. FDA awards $2.6M grant for expanded study of Soligenix's HyBryte for skin cancer | N/A | |
| 2022-09-06 15:04 EST | News | Soligenix announces $2.6M FDA grant to further study blood cancer candidate | N/A | |
| 2022-08-13 01:22 EST | News | Soligenix GAAP EPS of -$0.06 beats by $0.03, revenue of $0.4M beats by $0.2M | N/A | |
| 2022-07-27 09:54 EST | News | Soligenix gets agreement from FDA for photodynamic therapy study in kids for lymphoma | N/A | |
| 2022-07-25 18:39 EST | News | Soligenix, SERB Pharma team up to develop therapy for ricin poisoning | N/A | |
| 2022-06-28 10:09 EST | News | Soligenix gains 11% on FDA nod to start mid-stage trial for psoriasis candidate | N/A | |
| 2022-05-24 03:57 EST | News | Soligenix gains on potential U.S. patent win for vaccine platform | N/A | |
| 2022-05-14 03:42 EST | News | Soligenix GAAP EPS of -$0.10 misses by $0.03, revenue of $0.2M beats by $0.1M | N/A | |
| 2022-03-29 11:31 EST | News | Soligenix GAAP EPS of -$0.31 misses by $0.01, revenue of $0.8M beats by $0.08M | N/A | |
| 2022-03-17 22:48 EST | News | Soligenix rises on data from animal study for booster COVID-19 shot | N/A | |
| 2022-01-04 18:28 EST | News | Soligenix shares non-clinical data to support efficacy of experimental cancer drug | N/A | |
| 2021-12-03 01:25 EST | News | Soligenix reports 100% protection using a bivalent thermostabilized filovirus vaccine | N/A | |
| 2021-11-12 08:49 EST | News | Soligenix EPS beats by $0.03, misses on revenue | N/A | |
| 2021-09-22 06:43 EST | News | Soligenix expects more funding from govt. efforts to combat future biological threats | N/A | |
| 2021-09-09 12:09 EST | News | Soligenix shares surge 21% after FDA Orphan Drug status for hypericin | N/A | |
| 2021-09-03 22:52 EST | News | Soligenix treatment of T-cell lymphoma nabs FDA Orphan Drug status, shares up 6% | N/A | |
| 2021-08-18 17:29 EST | News | Soligenix highlights the potential of its multivalent vaccines, shares rise 18% | N/A | |
| 2021-08-13 21:07 EST | News | Soligenix EPS beats by $0.06, misses on revenue | N/A | |
| 2021-07-22 01:49 EST | News | Soligenix receives non-dilutive funding through New Jersey Technology Business Tax Certificate Transfer Program | N/A | |
| 2021-07-22 01:49 EST | News | Soligenix soars 13% after securing PIP waiver for HyBryte in blood cancer in Europe | N/A | |
| 2021-07-22 01:40 EST | News | Soligenix reports positive HyBryte data in late-stage cutaneous T-cell lymphoma study | N/A | |
| 2021-03-30 12:59 EST | News | Soligenix EPS misses by $0.10, beats on revenue | N/A | |
| 2021-03-04 09:08 EST | News | Soligenix surges on favorable preclinical work of its COVID-19 vaccine candidate | N/A | |
| 2021-01-29 08:34 EST | Analyst Rating | The Analyst Target Price has decreased from $5.55 to $3.85. | Neutral | |
| 2021-01-15 08:35 EST | Analyst Rating | The Analyst Target Price has decreased from $5.75 to $5.55. | Neutral | |
| 2021-01-07 16:58 EST | News | Soligenix inks supply and distribution deal for SGX301 companion light device in cancer | N/A | |
| 2021-01-01 08:43 EST | Analyst Rating | The Analyst Target Price has decreased from $6.15 to $5.75. | Neutral | |
| 2020-12-28 14:34 EST | News | Soligenix receives $1.5M grant advancing COVID-19 vaccine development | N/A | |
| 2020-12-24 08:53 EST | Analyst Rating | The Analyst Target Price has decreased from $6.45 to $6.15. | Neutral | |
| 2020-12-22 08:52 EST | News | Soligenix's SGX942 flunks oral mucositis study in cancer patients, shares plummet 44% | N/A | |
| 2020-12-16 12:06 EST | News | Soligenix announces $20M strategic convertible debt financing agreement | N/A | |
| 2020-12-07 05:02 EST | Analyst Rating | The Analyst Target Price has decreased from $7.06 to $6.45. | Neutral | |
| 2020-11-26 21:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-17 12:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-13 13:23 EST | Earnings Estimate | An EPS average of -$0.11 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-11-13 09:48 EST | News | Soligenix EPS beats by $0.07, misses on revenue | N/A | |
About Soligenix, Inc (SNGX):
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301, a novel photodynamic therapy, which has completed Phase 3 clinical trial to treat cutaneous T-cell lymphoma; and SGX942, an innate defense regulator technology that is in Phase 3 clinical trial to treat oral mucositis in head and neck cancer. This segment also offers proprietary formulations of oral beclomethasone 17,21-dipropionate, which is in Phase 1/2 clinical trial for the prevention/treatment of gastrointestinal disorders characterized by severe inflammation, including pediatric Crohn's disease and acute radiation enteritis. The Public Health Solutions segment is involved in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase 1a and 1b clinical trials; SGX943, a melioidosis therapeutic candidate that is in pre-clinical stage for the treatment of antibiotic resistant and emerging infectious diseases; and ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey.
General
- Name Soligenix, Inc
- Symbol SNGX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 15
- Last Split Factor1:10
- Last Split Date2016-10-07
- Fiscal Year EndDecember
- IPO Date1987-06-15
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.soligenix.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 17.11
- Price/Book (Most Recent Quarter) 7.87
- Enterprise Value Revenue 17.47
View More
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.12
- Operating Margin -602%
- Return on Assets -95%
- Return on Equity -298%
- Revenue 2.72 million
- Earnings Per Share -$0.49
- Revenue Per Share $0.11
- Gross Profit 1.06 million
- Quarterly Earnings Growth -51.5%
View More
Highlights
- Market Capitalization 55.1 million
- EBITDA -9495876
- PEG Ratio -1.52
- Analyst Target Price $3.85
- Book Value Per Share $0.25
View More
Share Statistics
- Shares Outstanding 31.49 million
- Shares Float 29.75 million
- % Held by Insiders 385%
- % Held by Institutions 11.71%
- Shares Short 2.13 million
- Shares Short Prior Month 1.54 million
- Short Ratio 0.42
- Short % of Float 7%
- Short % of Shares Outstanding 7%
View More
Technicals
- Beta 1.31
- 52 Week High $2.99
- 52 Week Low $1.21
- 50 Day Moving Average 1.75
- 200 Day Moving Average 1.82
View More
Dividends
- Dividend Date 2016-10-07
- ExDividend Date N/A
- Dividend Yield 0%
View More
Soligenix, Inc (SNGX) Dividend Calendar:
SNGX's last dividend payment was made to shareholders on October 7, 2016.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Soligenix, Inc (SNGX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-12 | $608811 | -$0.06 | -$0.13 | 52.64% |
| 2020-06-30 | 2020-08-14 | $N/A | -$0.10 | -$0.14 | 30.22% |
| 2020-03-31 | 2020-05-15 | $924552 | -$0.32 | -$0.13 | -146.15% |
| 2019-12-31 | 2020-03-30 | $N/A | -$0.14 | -$0.14 | 0% |
| 2019-09-30 | 2019-11-12 | $1.25 million | -$0.14 | -$0.13 | -7.69% |
| 2019-06-30 | 2019-08-13 | $1.54 million | -$0.12 | -$0.14 | 12.22% |
| 2019-03-31 | 2019-05-14 | $1.14 million | -$0.09 | -$0.14 | 33.33% |
| 2018-12-31 | 2019-03-26 | $-1381353 | -$0.18 | -$0.11 | -58.87% |
| 2018-09-30 | 2018-11-09 | $1.38 million | -$0.11 | -$0.11 | 0% |
| 2018-06-30 | 2018-08-08 | $1.73 million | -$0.18 | -$0.20 | 10% |
| 2018-03-31 | 2018-05-11 | $1.12 million | -$0.27 | ||
| 2017-12-31 | 2018-03-15 | $1.29 million | -$0.27 | -$0.27 | -1.24% |
| 2017-09-30 | 2017-11-06 | $1.82 million | -$0.17 | -$0.40 | 56.96% |
| 2017-06-30 | 2017-08-11 | $991000 | -$0.41 | -$0.33 | -26.15% |
| 2017-03-31 | 2017-05-11 | $1.33 million | -$0.32 | -$0.30 | -6.67% |
| 2016-12-31 | 2017-03-27 | $1.7 million | -$0.04 | -$1.76 | 97.73% |
| 2016-09-30 | 2016-11-10 | $2.96 million | -$0.49 | -$0.50 | 2% |
| 2016-06-30 | 2016-08-11 | $3.16 million | -$0.20 | -$0.90 | 77.78% |
| 2016-03-31 | 2016-05-12 | $2.63 million | -$0.40 | -$0.60 | 33.33% |
| 2015-12-31 | 2016-03-24 | $2.97 million | -$1.00 | -$0.90 | -11.11% |
| 2015-09-30 | 2015-11-12 | $3.88 million | $1.00 | -$0.80 | 225% |
| 2015-06-30 | 2015-08-12 | $1.1 million | -$1.50 | -$1.50 | 0% |
| 2015-03-31 | 2015-05-14 | $816000 | -$1.90 | -$1.20 | -58.33% |
| 2014-12-31 | 2015-03-24 | $1.93 million | $1.10 | -$0.60 | 283.33% |
| 2014-09-30 | 2014-11-10 | $2.79 million | -$2.10 | -$0.87 | -141.38% |
| 2014-06-30 | 2014-08-11 | $1.42 million | -$0.50 | -$0.90 | 44.44% |
| 2014-03-31 | 2014-05-12 | $911000 | -$1.70 | -$0.70 | -142.86% |
| 2013-12-31 | 2014-03-26 | $1.38 million | $1.30 | -$0.75 | 273.33% |
| 2013-09-30 | 2013-11-12 | $312000 | -$3.40 | -$0.85 | -300% |
| 2013-06-30 | 2013-08-12 | $633000 | -$1.00 | -$0.70 | -42.86% |
| 2013-03-31 | 2013-05-03 | $900000 | -$1.00 | -$1.30 | 23.08% |
| 2012-12-31 | 2013-02-26 | $803000 | -$0.90 | -$0.30 | -200% |
| 2012-09-30 | 2012-11-09 | $932000 | -$0.68 | ||
| 2012-06-30 | 2012-08-10 | $763000 | -$0.88 | ||
| 2012-03-31 | 2012-05-11 | $647000 | -$1.29 | ||
| 2011-12-31 | 2012-03-27 | $653000 | -$0.85 | ||
| 2011-09-30 | 2011-11-14 | $5.8 million | $2.00 | -$2.00 | 200% |
| 2011-06-30 | 2011-08-12 | $406000 | -$2.00 | -$2.00 | 0% |
| 2011-03-31 | 2011-05-13 | $808000 | -$2.00 | -$2.00 | 0% |
| 2010-12-31 | 2011-03-29 | $307000 | -$2.00 | -$2.00 | 0% |
| 2010-09-30 | 2010-11-12 | $860000 | -$2.00 | -$2.00 | 0% |
| 2010-06-30 | 2010-08-13 | $445000 | -$2.00 | -$2.00 | 0% |
| 2010-03-31 | 2010-05-17 | $336000 | -$2.00 | -$2.00 | 0% |
| 2009-09-30 | 2009-11-14 | $767000 | -$1.98 | ||
| 2009-06-30 | 2009-08-14 | $333000 | -$2.14 | ||
| 2009-03-31 | 2009-05-15 | $530000 | -$2.88 | ||
| 2008-12-31 | 2009-03-26 | $538000 | -$1.07 | ||
| 2008-09-30 | 2008-11-14 | $606000 | -$0.93 | ||
| 2008-06-30 | 2008-08-15 | $488000 | -$2.52 | ||
| 2008-03-31 | 2008-05-16 | $678000 | -$2.77 | ||
| 2007-09-30 | 2007-11-13 | $429000 | -$2.68 | ||
| 2007-06-30 | 2007-08-15 | $280000 | -$3.36 | ||
| 2007-03-31 | 2007-05-16 | $235000 | -$5.24 | ||
| 2006-12-31 | 2007-03-12 | $669000 | -$5.47 | ||
| 2006-09-30 | 2006-11-14 | $118000 | -$3.99 | ||
| 2006-06-30 | 2006-08-14 | $138000 | -$9.99 | ||
| 2006-03-31 | 2006-05-15 | $1.39 million | -$6.66 | ||
| 2005-12-31 | 2006-03-30 | $806000 | -$6.00 | ||
| 2005-09-30 | 2005-11-14 | $734000 | -$4.69 | ||
| 2005-06-30 | 2005-08-15 | $1.42 million | -$2.14 | ||
| 2005-03-31 | 2005-05-16 | $114000 | -$4.38 | ||
| 2004-12-31 | 2005-03-14 | $931000 | -$10.00 | ||
| 2004-09-30 | 2004-11-15 | $N/A | -$6.00 | -$12.00 | 50% |
| 2004-06-30 | 2004-08-13 | $-66000 | -$7.04 | ||
| 2004-03-31 | 2004-05-16 | $66000 | -$9.07 | ||
| 2003-12-31 | 2004-03-31 | $84000 | -$10.00 | -$10.00 | 0% |
| 2003-09-30 | 2003-11-19 | $N/A | -$9.41 | ||
| 2003-06-30 | 2003-08-13 | $N/A | -$5.85 | ||
| 2003-03-31 | 2003-03-31 | $N/A | -$19.44 | ||
| 2002-12-31 | 2003-03-31 | $N/A | -$8.00 | -$8.00 | 0% |
| 2002-09-30 | 2002-09-30 | $N/A | -$9.55 | ||
| 2002-06-30 | 2002-06-30 | $N/A | -$17.88 | ||
| 2002-03-31 | 2002-03-31 | $N/A | -$22.52 | ||
| 2001-09-30 | 2001-09-30 | $N/A | -$22.94 | ||
| 2001-06-30 | 2001-06-30 | $N/A | -$24.37 | ||
| 2001-03-31 | 2001-03-31 | $N/A | -$24.74 | ||
| 2000-09-30 | 2000-09-30 | $N/A | -$22.82 | ||
| 2000-06-30 | 2000-06-30 | $N/A | -$26.22 | ||
| 2000-03-31 | 2000-03-31 | $N/A | -$32.96 | ||
| 1999-09-30 | 1999-09-30 | -$36.14 | |||
| 1999-06-30 | 1999-06-30 | -$48.51 | |||
| 1999-03-31 | 1999-03-31 | -$42.97 | |||
| 1998-09-30 | 1998-09-30 | -$33.80 | |||
| 1998-06-30 | 1998-06-30 | -$30.46 | |||
| 1998-03-31 | 1998-03-31 | -$183.22 |
Soligenix, Inc (SNGX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Soligenix, Inc (SNGX) Chart:
Soligenix, Inc (SNGX) News:
Below you will find a list of latest news for Soligenix, Inc (SNGX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Soligenix, Inc (SNGX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest SNGX Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:51 PM EST | 100 | $0.61 |
| Jun 13, 2022 7:52 PM EST | 100 | $0.61 |
| Jun 13, 2022 7:52 PM EST | 100 | $0.61 |
| Jun 13, 2022 7:55 PM EST | 101 | $0.6101 |
| Jun 13, 2022 7:57 PM EST | 100 | $0.62 |
Soligenix, Inc (SNGX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390020015362/0001213900-20-015362-index.htm |
| 2017-11-28 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/812796/000000000017041760/0000000000-17-041760-index.htm |
| 2020-07-24 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/812796/000000000020006786/0000000000-20-006786-index.htm |
| 2018-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/812796/000101905618000316/0001019056-18-000316-index.htm |
| 2018-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/812796/000110465918008949/0001104659-18-008949-index.htm |
| 2018-07-30 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/812796/000110465918048060/0001104659-18-048060-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/812796/000110465919007980/0001104659-19-007980-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/812796/000110465920012480/0001104659-20-012480-index.htm |
| 2020-04-23 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/812796/000119312520117150/0001193125-20-117150-index.htm |
| 2020-05-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/812796/000119312520134872/0001193125-20-134872-index.htm |
| 2017-11-20 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/812796/000121390017012407/0001213900-17-012407-index.htm |
| 2017-11-28 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/812796/000121390017012687/0001213900-17-012687-index.htm |
| 2017-11-30 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/812796/000121390017012796/0001213900-17-012796-index.htm |
| 2017-12-01 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/812796/000121390017012849/0001213900-17-012849-index.htm |
| 2017-12-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390017012851/0001213900-17-012851-index.htm |
| 2017-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390017013087/0001213900-17-013087-index.htm |
| 2017-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390017013089/0001213900-17-013089-index.htm |
| 2017-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390017013091/0001213900-17-013091-index.htm |
| 2017-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390017013093/0001213900-17-013093-index.htm |
| 2018-01-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390018000853/0001213900-18-000853-index.htm |
| 2018-03-15 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/812796/000121390018003007/0001213900-18-003007-index.htm |
| 2018-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/812796/000121390018005960/0001213900-18-005960-index.htm |
| 2018-05-25 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/812796/000121390018006892/0001213900-18-006892-index.htm |
| 2018-06-18 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/812796/000121390018007821/0001213900-18-007821-index.htm |
| 2018-06-20 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/812796/000121390018007967/0001213900-18-007967-index.htm |
| 2018-06-29 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/812796/000121390018008458/0001213900-18-008458-index.htm |
| 2018-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390018008611/0001213900-18-008611-index.htm |
| 2018-07-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390018009405/0001213900-18-009405-index.htm |
| 2018-07-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390018009606/0001213900-18-009606-index.htm |
| 2018-07-25 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390018009608/0001213900-18-009608-index.htm |
| 2018-07-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390018009610/0001213900-18-009610-index.htm |
| 2018-07-31 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/812796/000121390018009954/0001213900-18-009954-index.htm |
| 2018-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/812796/000121390018010449/0001213900-18-010449-index.htm |
| 2018-08-10 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/812796/000121390018010701/0001213900-18-010701-index.htm |
| 2018-08-10 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/812796/000121390018010702/0001213900-18-010702-index.htm |
| 2018-08-17 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/812796/000121390018011350/0001213900-18-011350-index.htm |
| 2018-08-17 | DEFR14A | Revised definitive proxy soliciting materials | https://www.sec.gov/Archives/edgar/data/812796/000121390018011352/0001213900-18-011352-index.htm |
| 2018-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390018011576/0001213900-18-011576-index.htm |
| 2018-09-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390018013207/0001213900-18-013207-index.htm |
| 2018-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390018013220/0001213900-18-013220-index.htm |
| 2018-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390018013223/0001213900-18-013223-index.htm |
| 2018-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390018013226/0001213900-18-013226-index.htm |
| 2018-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390018013229/0001213900-18-013229-index.htm |
| 2018-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390018013232/0001213900-18-013232-index.htm |
| 2018-10-03 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/812796/000121390018013446/0001213900-18-013446-index.htm |
| 2018-10-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390018013449/0001213900-18-013449-index.htm |
| 2018-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390018013884/0001213900-18-013884-index.htm |
| 2018-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390018014061/0001213900-18-014061-index.htm |
| 2018-10-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390018014092/0001213900-18-014092-index.htm |
| 2018-11-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/812796/000121390018015302/0001213900-18-015302-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390018017378/0001213900-18-017378-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390018017380/0001213900-18-017380-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390018017381/0001213900-18-017381-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390018017382/0001213900-18-017382-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019000215/0001213900-19-000215-index.htm |
| 2019-03-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390019004250/0001213900-19-004250-index.htm |
| 2019-03-26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/812796/000121390019004865/0001213900-19-004865-index.htm |
| 2019-04-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019006871/0001213900-19-006871-index.htm |
| 2019-04-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019006872/0001213900-19-006872-index.htm |
| 2019-04-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390019006958/0001213900-19-006958-index.htm |
| 2019-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/812796/000121390019008583/0001213900-19-008583-index.htm |
| 2019-07-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390019012259/0001213900-19-012259-index.htm |
| 2019-07-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019012261/0001213900-19-012261-index.htm |
| 2019-07-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019012268/0001213900-19-012268-index.htm |
| 2019-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019012450/0001213900-19-012450-index.htm |
| 2019-07-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/812796/000121390019013717/0001213900-19-013717-index.htm |
| 2019-07-26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/812796/000121390019013720/0001213900-19-013720-index.htm |
| 2019-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390019014172/0001213900-19-014172-index.htm |
| 2019-08-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/812796/000121390019015532/0001213900-19-015532-index.htm |
| 2019-08-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390019016944/0001213900-19-016944-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019017650/0001213900-19-017650-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019017652/0001213900-19-017652-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019017654/0001213900-19-017654-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019017656/0001213900-19-017656-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019017658/0001213900-19-017658-index.htm |
| 2019-09-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390019017733/0001213900-19-017733-index.htm |
| 2019-09-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019017736/0001213900-19-017736-index.htm |
| 2019-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019017740/0001213900-19-017740-index.htm |
| 2019-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390019018249/0001213900-19-018249-index.htm |
| 2019-09-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019018664/0001213900-19-018664-index.htm |
| 2019-09-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019018706/0001213900-19-018706-index.htm |
| 2019-10-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390019020617/0001213900-19-020617-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/812796/000121390019022914/0001213900-19-022914-index.htm |
| 2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019024070/0001213900-19-024070-index.htm |
| 2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019024072/0001213900-19-024072-index.htm |
| 2019-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019026151/0001213900-19-026151-index.htm |
| 2019-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019026152/0001213900-19-026152-index.htm |
| 2019-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019026153/0001213900-19-026153-index.htm |
| 2019-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390019026154/0001213900-19-026154-index.htm |
| 2019-12-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390019026324/0001213900-19-026324-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390020000043/0001213900-20-000043-index.htm |
| 2020-01-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390020000155/0001213900-20-000155-index.htm |
| 2020-01-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390020000941/0001213900-20-000941-index.htm |
| 2020-03-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390020006814/0001213900-20-006814-index.htm |
| 2020-03-20 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/812796/000121390020006965/0001213900-20-006965-index.htm |
| 2020-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390020006968/0001213900-20-006968-index.htm |
| 2020-03-30 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/812796/000121390020007959/0001213900-20-007959-index.htm |
| 2020-04-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390020008553/0001213900-20-008553-index.htm |
| 2020-04-10 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/812796/000121390020008977/0001213900-20-008977-index.htm |
| 2020-04-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390020008980/0001213900-20-008980-index.htm |
| 2020-04-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390020009025/0001213900-20-009025-index.htm |
| 2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390020010550/0001213900-20-010550-index.htm |
| 2020-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/812796/000121390020012580/0001213900-20-012580-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390020015362/0001213900-20-015362-index.htm |
| 2020-07-17 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/812796/000121390020017821/0001213900-20-017821-index.htm |
| 2020-07-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390020017869/0001213900-20-017869-index.htm |
| 2020-07-24 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/812796/000121390020018540/0001213900-20-018540-index.htm |
| 2020-07-31 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/812796/000121390020019648/0001213900-20-019648-index.htm |
| 2020-07-31 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/812796/000121390020019650/0001213900-20-019650-index.htm |
| 2020-08-07 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/812796/000121390020020913/0001213900-20-020913-index.htm |
| 2020-08-07 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/812796/000121390020020914/0001213900-20-020914-index.htm |
| 2020-08-13 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/812796/000121390020021901/0001213900-20-021901-index.htm |
| 2020-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/812796/000121390020022284/0001213900-20-022284-index.htm |
| 2020-08-14 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/812796/000121390020022324/0001213900-20-022324-index.htm |
| 2020-08-26 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/812796/000121390020023838/0001213900-20-023838-index.htm |
| 2020-08-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390020024260/0001213900-20-024260-index.htm |
| 2020-08-28 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/812796/000121390020024268/0001213900-20-024268-index.htm |
| 2020-09-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390020025945/0001213900-20-025945-index.htm |
| 2020-09-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/812796/000121390020027370/0001213900-20-027370-index.htm |
| 2020-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390020027372/0001213900-20-027372-index.htm |
| 2020-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390020027373/0001213900-20-027373-index.htm |
| 2020-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390020027374/0001213900-20-027374-index.htm |
| 2020-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/812796/000121390020027375/0001213900-20-027375-index.htm |
| 2020-10-23 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/812796/000121390020033027/0001213900-20-033027-index.htm |
| 2020-11-06 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/812796/000121390020035601/0001213900-20-035601-index.htm |
| 2018-07-09 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/812796/000121465918004795/0001214659-18-004795-index.htm |
| 2017-11-30 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/812796/999999999517003097/9999999995-17-003097-index.htm |
| 2018-06-27 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/812796/999999999518001638/9999999995-18-001638-index.htm |
| 2020-08-28 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/812796/999999999520002302/9999999995-20-002302-index.htm |
Soligenix, Inc (SNGX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Soligenix, Inc (SNGX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 385%Institutional Ownership: 1171%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2017-11-29 | SPA Essetifin | Insider | Sell | 271,140.00 | 2.12 | 574,816.80 | 0.00 | https://www.sec.gov/Archives/edgar/data/812796/000121390017012851/0001213900-17-012851-index.htm |
| 2019-09-23 | Diane L. Parks | Director | Buy | 14,940.00 | 0.93 | 13,870.30 | 14,940.00 | https://www.sec.gov/Archives/edgar/data/812796/000121390019018706/0001213900-19-018706-index.htm |
| 2019-04-22 | JEROME B ZELDIS | Director | Buy | 10,000.00 | 0.73 | 7,274.00 | 16,917.00 | https://www.sec.gov/Archives/edgar/data/812796/000121390019006872/0001213900-19-006872-index.htm |
| 2019-09-19 | JEROME B ZELDIS | Director | Buy | 4,000.00 | 0.94 | 3,740.00 | 20,917.00 | https://www.sec.gov/Archives/edgar/data/812796/000121390019018664/0001213900-19-018664-index.htm |
| 2019-11-19 | JEROME B ZELDIS | Director | Buy | 2,000.00 | 0.93 | 1,850.00 | 22,917.00 | https://www.sec.gov/Archives/edgar/data/812796/000121390019024072/0001213900-19-024072-index.htm |
| 2018-10-17 | Mark E. Pearson | Director | Buy | 170,000.00 | 1.16 | 197,200.00 | 2,500,000.00 | https://www.sec.gov/Archives/edgar/data/812796/000121390018014061/0001213900-18-014061-index.htm |
| 2017-11-29 | SPA Essetifin | Insider | Buy | 271,140.00 | 2.12 | 574,816.80 | 271,140.00 | https://www.sec.gov/Archives/edgar/data/812796/000121390017012851/0001213900-17-012851-index.htm |
| 2017-11-29 | SPA Essetifin | Insider | Buy | 5,954.00 | 2.12 | 12,622.48 | 277,094.00 | https://www.sec.gov/Archives/edgar/data/812796/000121390017012851/0001213900-17-012851-index.htm |
| 2018-08-22 | CHRISTOPHER J SCHABER | Chairman, CEO and President | Buy | 3,530.00 | 1.42 | 5,011.89 | 28,625.00 | https://www.sec.gov/Archives/edgar/data/812796/000121390018011576/0001213900-18-011576-index.htm |
| 2017-11-29 | SPA Essetifin | Insider | Buy | 16,416.00 | 2.12 | 34,801.92 | 293,510.00 | https://www.sec.gov/Archives/edgar/data/812796/000121390017012851/0001213900-17-012851-index.htm |
| 2018-10-18 | CHRISTOPHER J SCHABER | Chairman, CEO and President | Buy | 8,700.00 | 1.17 | 10,177.26 | 37,325.00 | https://www.sec.gov/Archives/edgar/data/812796/000121390018014092/0001213900-18-014092-index.htm |
| 2019-04-22 | CHRISTOPHER J SCHABER | Chairman, CEO and President | Buy | 5,000.00 | 0.72 | 3,577.00 | 42,325.00 | https://www.sec.gov/Archives/edgar/data/812796/000121390019006871/0001213900-19-006871-index.htm |
| 2019-11-19 | CHRISTOPHER J SCHABER | Chairman, CEO and President | Buy | 10,770.00 | 0.93 | 10,016.10 | 53,095.00 | https://www.sec.gov/Archives/edgar/data/812796/000121390019024070/0001213900-19-024070-index.htm |
| 2019-06-28 | Mark E. Pearson | Director | Buy | 78,338.00 | 0.71 | 55,619.98 | 78,338.00 | https://www.sec.gov/Archives/edgar/data/812796/000121390019012450/0001213900-19-012450-index.htm |